Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nebojsa Stankovic is active.

Publication


Featured researches published by Nebojsa Stankovic.


Military Medicine | 2007

Effects of Acclimation on Cognitive Performance in Soldiers during Exertional Heat Stress

Sonja Radakovic; Jelena Maric; Maja Surbatovic; Slavica Radjen; Elka Stefanova; Nebojsa Stankovic; Nikola Filipovic

This study investigates the effects of exertional heat stress and acclimation status on physiological and cognitive performance. Forty male soldiers performed an exertional heat stress test (EHST) either in a cool (20 degrees C, 16 degrees C wet bulb globe temperature), or in a hot environment (40 degrees C, 29 degrees C wet bulb globe temperature), unacclimatized, or after 10 days of passive or active acclimation. Mean skin and tympanic (Tty) temperatures and heart rates (HR) measured physiological strain. A cognitive test (the computerized Cambridge Neuropsychological Test Automated Batteries attention battery) is administered before and immediately after EHST. EHST in hot conditions induced physiological heat stress (increase in Tty and HR), which caused mild deficits in attention in U group (decreased number of correct responses, and prolonged movement time). Acclimated (passive and active) soldiers suffered no detrimental effects of exertional heat stress, despite almost the same degree of heat strain, measured by Tty and HR.


Military Medicine | 2007

Immune Cytokine Response in Combat Casualties: Blast or Explosive Trauma with or without Secondary Sepsis

Maja Surbatovic; Nikola Filipovic; Sonja Radakovic; Nebojsa Stankovic; Zoran Slavkovic

The aim of this study was to assess the prognostic value of tumor necrosis factor (TNF) alpha, interleukin (IL)-8, IL-4, and IL-10 in combat casualties. Fifty-six casualties with severe trauma (blast and explosive) who developed sepsis and 20 casualties with the same severity of trauma without sepsis were enrolled in this study. Fifty-five casualties developed multiple organ dysfunction syndrome; 36 died. Blood was drawn on the first day of trauma. Concentrations of IL-8, TNF-alpha, IL-4, and IL-10 were determined in plasma using enzyme-linked immunosorbent assays. Mean values of IL-8 were 230-fold, IL-10 were 42-fold, and TNF-alpha were 17-fold higher in trauma and sepsis group (p < 0.01). Mean values of IL-8 were 60-fold, TNF-alpha were 43.5-fold, and IL-10 were 70-fold higher in the multiple organ dysfunction syndrome group (p < 0.01). Mean values of IL-8 were 2.3-fold and IL-10 were 1.4-fold higher in nonsurvivors and TNF-alpha were 2.2-fold higher in survivors (p < 0.01). IL-4 had no significance as a predictor of severity and outcome.


Vojnosanitetski Pregled | 2008

Adverse effects of long term, continual administration of high doses of albendazole in the treatment of echinococcal disease

Miodrag Jevtic; Dragan Mikic; Gordana Arsic-Komljenovic; Nebojsa Stankovic; Elizabeta Ristanovic; Goran Sjenicic; Snezana Janicijevic-Hudomal

BACKGROUND/AIM Modern treatment of cystic echinococcosis, except for surgical treatment and percutaneous drainage of cyst considers also administration of albendazole as a type of individual therapy. However, clinicians fear of the serious adverse effects of high doses of albendazole, first of all the elevation of serum transaminases activity, very frequently results in subdosing of albendazole and wrong conclusions its efficacy and safety. The aim of this study was to investigate adverse effects of a longterm, continual administration of high doses of albendazole in the treatment of patients with echinococcal disease. METHODS A total of 42 patients (mean age 40.4 +/- 18.3 years) with echinococcal disease were included in the study. They were treated with continual administration of high doses of albendazole within the period of 4 to 6 months. The subgroups of 27 and 15 patients were treated with 15-20 mg/kg/day and with 21-25 mg/kg/day albendazole, respectively. The patients in the control group (18 with surgical treatment, 6 with percutaneous drainage of cyst) were treated with 800 mg albendazole per day (< 15 mg/kg body weight) in the cycles of 28 days (1-3 cycles) and a two-week pause between them. RESULTS In the study group adverse effects of albendazole were registered in 20 (47.6%), whereas in the control group in 6 (30.0%) of the patients. In both subgroups elevated activity of serum transaminases were found more frequently in the study group compared to the control one (35.7% vs 25%, p < 0.05), especially in the patients who were treated with higher doses of albendazole. The patients in the study group, compared to the patients in the control group had significantly higher mean activity of serum alanin aminotransferase in the course of the second and third month of the therapy (p < 0.05). Administration of albendazole due to adverse effects was stopped in 3 (7.1%) of the patients in the study group. Two (4.8%) of them had a very high activity of serum transaminases and one had a muscle pains and high activity of serum creatine kinase. After the interruption of the therapy we documented a nonnalization of serum enzyme levels in all the patients. CONCLUSION Longterm, continual administration of high doses of albendazole in the patients with echinococcal disease results in significant elevation of serum transaminases activity, compared to the patients treated with albendazole in the cycles, but in the majority of the patients serum transaminases activity was normalizated by the end of a 6-month period.


Vojnosanitetski Pregled | 2009

Mesoatrial shunt in Budd-Chiari syndrome

Darko Mirkovic; Nebojsa Stankovic; Miodrag Jevtic; Miroslav Mitrovic; Milan Jovanovic

BACKGROUND Budd-Chiari syndrome (BCS) represents partial or total occlusion of the hepatic veins with or without simultaneous obstruction of vena cava inferior (VCI). The symptoms of BCS are abdominal pain, hepatomegaly, ascites, varices of the abdominal wall, sometimes bleeding from the upper part of gastointestinal tract (GIT), lower limbs swelling and jaundice. Primary BSC is a relatively rare condition occuring in one per 100,000 of the population worldwide. CASE REPORT A male patient, 25-year-old, facing tooth postextraction complications, was presented with acute BCS. On admission, physical examination revealed pale-grayish complexion, more pronounced veins over the thorax and abdomen, ascites, enlarged liver rising 8 cm below the right costal arch and having a minor pleural effusion by the right side. The patient was submitted to Doppler sonography and computed tomography (CT) that verified the right leg deep veins thrombosis, as well as the presence of a thrombus in the intrahepatic portion of the VCI. Multislice computed tomography (MSCT) showed occlusion of hepatic veins (Budd-Chiari syndrome) and thrombosis of the VCI in the retrohepatic part 6 cm long. Also, increased values of transaminases and gamma GT and reduced values of albumines and serum ferrum were registered. Molecular examination revealed Factor V Leiden mutation--heterozygote. After preoperative preparations a mesocaval shunt was made using Gore-Tex ring graft of 12 mm. Intraoperatively, the blue enlarged liver was found with almost black zones of tense capsule. After a graft making, liver congestion decreased followed by the change of colour and volume. Within postoperative course metabolic and synthetic liver functions were obvious. CONCLUSION In patients with BCS medicamentous treatment does not yield adequate results, but even causes worsening of general condition. Surgical therapy in the presented patient was performed timely regarding the stage of the disease due to which irreversible liver changes were prevented while decompression of the portal system provided time overbridging up to liver transplantation.


Acta Chirurgica Iugoslavica | 2003

C-reaktivni protein kao pokazatelj težine ratne povrede

Sonja Radakovic; Maja Surbatovic; Milan Pavlica; Nebojsa Stankovic

During the general reaction to trauma, acute phase proteins are synthesized. The aim of the prospective study was to determine CRP concentrations in sera of war casualties during the first 14 posttraumatic days, and to establish the correlation between these changes and severity of trauma. Subjects were 79 war casualties. Controls: 33 blood donors. Methods: Injury severity was determined according to ISS and CRP concentrations with immunonephelometric analysis. Blood samples were collected 12 hours after trauma, then on the 1st, 2nd, 5th and 14th posttraumatic day. In war casualties CRP values were significantly increased (56.257.53 mg/dl after 12 hrs, 107.0976.08 on 1st, 144.3570.23 on 2nd, 71.42558.66 on 5th and 37.656.14 on 14th posttraumatic day; p). Significant differences were observed between groups with TSS and ISS 12 (p) in first two days and later between group with ISS24 (144.1766.94 mg/dl on 5th and 111.588.5 on 14th posttraumatic day) and others (p). Conclusions: During the acute-phase response to trauma, significant changes in concentration of CRP occur in sera of war casualties. These changes are the most promrninent during the first 48 hours, with tendency for normalization after the 5th day. Intensity of these changes depend of the severity of trauma. CRP is valid marker of war wound severity.


Vojnosanitetski Pregled | 2005

Significance of iron reduction for the therapy of chronic hepatitis C

Darko Nozic; Bela Balint; Nebojsa Stankovic; Jovan Dimitrijevic; Gorana Neskovic

BACKGROUND It has been established that many patients with chronic hepatitis C have elevated serum iron, feritin levels and iron deposites in the liver. Therefore, the liver damage due to hepatitis C virus may be aggravated with iron overload. In many studies higher levels of iron in the blood and the liver were connected with the decreased response to interferon-alfa therapy for chronic viral hepatitis C. Recent introduction of pegylated interferons plus ribavirin has improved the therapeutic response, so it is now possible to cure more than 50% of the patients. CASE REPORT Three patients with chronic hepatitis C and iron overload were presented. Iron reduction therapy using phlebotomy or eritrocytapheresis with plasmapheresis was done at different times in regard to specific antiviral therapy or as a sole therapy. CONCLUSION It has been shown that iron reduction, sole or combined with antiviral therapy, led to the deacreased aminotransferase serum activity and might have slown down the evolution of chronic hepatitis C viral infection.


Vojnosanitetski Pregled | 2011

Splenic artery pseudoaneurysm as a complication of pancreatic pseudocyst

Sasa Mickovic; Miroslav Mitrovic; Nebojsa Stankovic; Mihailo Bezmarevic; Milan Jovanovic; Darko Mirkovic; Ivana Tufegdzic; Irena Nikolic-Mickovic


Vojnosanitetski Pregled | 2005

Liver hydatid disease: morphological changes of protoscoleces after albendazole therapy

Nebojsa Stankovic; Mile D. Ignjatović; Darko Nozic; Zoran Hajdukovic


Vojnosanitetski Pregled | 2011

Epidemiology of nosocomial colonization/infection caused by Acinetobacter spp. in patients of six surgical clinics in war and peacetime

Vesna Suljagic; Miodrag Jevtic; Boban Djordjevic; Predrag Romic; Radoje Ilic; Nebojsa Stankovic; Novak Milovic; Marijan Novakovic; Jefta Kozarski; Roganović Z; Zoran Popovic; Aleksandra Jovelic


Vojnosanitetski Pregled | 2012

Major changes in the European Resuscitation Council Guidelines for Cardiopulmonary Resuscitation 2010 in the field of adult basic and advanced life support

Jasna Jevdjic; Maja Surbatovic; Nebojsa Stankovic; Violetta Raffay; Zlatko Fiser; Dusko Jovanovic

Collaboration


Dive into the Nebojsa Stankovic's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Darko Mirkovic

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Miodrag Jevtic

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sasa Mickovic

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge